Health officials in England have opened access to home self-testing kits for almost four million women who have missed their routine cervical screening appointments, allowing them to check for high-risk strains of human papillomavirus (HPV) outside a clinical setting.
The initiative is intended to reduce barriers to screening by giving eligible women the option to take a sample themselves. Health authorities say the kits are designed to identify high-risk types of HPV, the virus most commonly linked to cervical cancer, and are being offered to those who have not responded to standard screening invitations.
How the kits work
Self-sampling kits enable women to collect a vaginal swab at home and send it for laboratory testing to detect the presence of high-risk HPV. If a test returns a positive result, women will be advised on appropriate next steps and follow-up care through the usual clinical pathways.
Officials described the measure as part of wider efforts to increase uptake of cervical screening and to find cases earlier when treatment is most effective. The availability of home testing is expected to provide a more convenient option for people who face practical, personal or logistical obstacles to attending in-person appointments, while maintaining links to follow-up services for those who need them.
Eligibility and access
Eligible women who have missed screening invitations will be able to order a kit; health authorities have issued guidance on who qualifies and how to request a test. Public health officials emphasise that home testing is an alternative for those who do not attend routine face-to-face screening rather than a replacement for established clinical services.
The broader screening programme continues to encourage all eligible women to take part in cervical screening, whether by attending a clinical appointment or, where appropriate, by using a self-sampling kit to ensure early detection and treatment of potential abnormalities.